Masterclass with Dr Michael Sofia

During this one hour webinar, Michael Sofia will talk through his discovery of a cure for the viral disease hepatitis C, what he learnt along the way, how he dealt with risk and how he continued to strive to devise a drug to combat this infectious disease.

Dr Sofia created sofobuvir in 2007 and the drug was approved for use in 2013. More than 95 percent of patients with the most common form of hepatitis C can now be cured by the treatment. To add to his list of accolades, Dr Sofia was awarded the University of Edinburgh’s Cameron Prize for Therapeutics in 2020.*

Dr Sofia is currently Co-founder and Chief Scientific Officer at Arbutus Biopharma, a US based biopharmaceutical company dedicated to discovering, developing and commercialising a cure for patients suffering from chronic hepatitis B infection.

He will be available for a short Q&A and discussion session at the end of the webinar, offering insight and advice to those on route to drug discovery and with commercialisation ambitions.

This event will be of particular interest to PhD students, early career researchers, postdoctoral fellows and PIs with early stage ideas in life sciences interested in translation of research, accelerating science towards impact and developing skills for career progression.